Trials / Terminated
TerminatedNCT01413386
Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary Stent
A Randomized Clinical Trial Comparing Patency and Safety of the Paclitaxel Eluting Covered Metallic Biliary Stent (Niti-S Mira-Cover II Biliary Stent) to the Common Covered Metallic Biliary Stent.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Jong Taek, Lee · Industry
- Sex
- All
- Age
- 19 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Paclitaxel covered metal biliary stent is non-inferior to common covered metal biliary stent in their patency rate and safety at the 6 months after stenting.
Detailed description
Paclitaxel covered metal biliary stent (Niti-S Mira-Cover II Biliary Stent) is non-inferior to common covered metal biliary stent (Niti-S Biliary Stent\_ComVi type)in their patency rate and safety at the 6 months after stenting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | biliary stent | palliative treatment for malignant patients |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2013-04-18
- Completion
- 2013-04-23
- First posted
- 2011-08-10
- Last updated
- 2020-03-11
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01413386. Inclusion in this directory is not an endorsement.